Alesta Therapeutics Raises €65 Million Series a Financing to Advance Oral Small Molecules for Rare Diseases
Alesta Therapeutics完成6500万欧元A轮融资,以推进用于罕见疾病的口服小分子
Alesta Therapeutics Raises €65 Million Series a Financing to Advance Oral Small Molecules for Rare Diseases
Alesta Therapeutics完成6500万欧元A轮融资,以推进用于罕见疾病的口服小分子
使用浏览器的分享功能,分享给你的好友吧